Shuya Li

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 14

Top Topics

Randomized Controlled Trial

Acute Ischemic Stroke

Top Venues

Stroke and vascular neurology

International journal of stroke : official journal of the International Stroke Society

This page only lists publications with an associated author ORCID identifier.

Publications

Shuya Li, Hong-Qiu Gu, Baoyu Feng, Qiang Dong, Dongsheng Fan, Yun Xu, Suiqiang Zhu, Yong-Jun Wang
RhPro-UK in acute ischemic stroke within 4.5 h of stroke onset trial-2 (the PROST-2 study): Rationale and design of a multicenter, prospective, randomized, open-label, blinded-endpoint, controlled phase 3 non-inferiority trial. International journal of stroke : official journal of the International Stroke Society (2024)
Shuya Li, Hong-Qiu Gu, Hongguo Dai, Guozhi Lu, Yong-Jun Wang
Reteplase versus alteplase for acute ischaemic stroke within 4.5 hours (RAISE): rationale and design of a multicentre, prospective, randomised, open-label, blinded-endpoint, controlled phase 3 non-inferiority trial. Stroke and vascular neurology (2024)
Shuya Li, Hong-Qiu Gu, Baoyu Feng, Qiang Dong, Dongsheng Fan, Yun Xu, Sui Qiang Zhu, Yong-Jun Wang
RhPro-UK in acute ischemic stroke within 4.5 hours of stroke onset trial-2(The PROST-2 study): Rationale and design of a multicenter, prospective, randomized, open-label, blinded-endpoint, controlled phase 3 non-inferiority trial. International journal of stroke : official journal of the International Stroke Society (2024)
Yun-Yun Xiong, Liyuan Wang, Yuesong Pan, Mengxing Wang, Lee H Schwamm, Chunmiao Duan, Bruce C V Campbell, Shuya Li, Manjun Hao, Na Wu, Zhixin Cao, Shuangzhe Wu, Zi-Xiao Li, Yong-Jun Wang
Tenecteplase versus alteplase for acute ischaemic stroke in the elderly patients: a post hoc analysis of the TRACE-2 trial. Stroke and vascular neurology (2024)
Shuya Li, Run-Qi Wangqin, Yue-Song Pan, Aoming Jin, Hao Li, Lee H Schwamm, Marc Fisher, Bruce C V Campbell, Mark W Parsons, Ziran Wang, Hongguo Dai, Deyang Li, Runhui Li, Junhai Wang, David Wang, Yilong Wang, Xing-Quan Zhao, Zixiao Li, Huaguang Zheng, Yun-Yun Xiong, Xia Meng, Yong-Jun Wang
Outcomes associated to the time to treatment with intravenous tenecteplase for acute ischaemic stroke: subgroup analysis of the TRACE-2 randomised controlled clinical trial. Stroke and vascular neurology (2024)
Runhua Zhang, Gaifen Liu, Xing-Quan Zhao, Yilong Wang, Zi-Xiao Li, Guofang Chen, Bo Liu, Yun Ling, Yong-Jun Wang, Shuya Li
Safety and efficacy of GD-11 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial. Stroke and vascular neurology (2024)
Shuya Li, Xuechun Wang, Aoming Jin, Gaifen Liu, Hong-Qiu Gu, Hao Li, Bruce C V Campbell, Marc Fisher, Yi Yang, Yan Wei, Junhai Wang, Yilong Wang, Xing-Quan Zhao, Li-Ping Liu, Zi-Xiao Li, Xia Meng, Yong-Jun Wang
Safety and Efficacy of Reteplase Versus Alteplase for Acute Ischemic Stroke: A Phase 2 Randomized Controlled Trial. Stroke 55 (2) (2023)
Shuya Li, Xuechun Wang, Aoming Jin, Gaifen Liu, Hong-Qiu Gu, Hao Li, Bruce C V Campbell, Marc Fisher, Yi Yang, Yan Wei, Junhai Wang, Yilong Wang, Xing-Quan Zhao, Li-Ping Liu, Zi-Xiao Li, Xia Meng, Yong-Jun Wang
Safety and Efficacy of Reteplase Versus Alteplase for Acute Ischemic Stroke: A Phase 2 Randomized Controlled Trial. Stroke (2023)
Shuya Li, Xuechun Wang, Aoming Jin, Gaifen Liu, Hong-Qiu Gu, Hao Li, Bruce C V Campbell, Marc Fisher, Yi Yang, Yan Wei, Junhai Wang, Yilong Wang, Xing-Quan Zhao, Li-Ping Liu, Zi-Xiao Li, Xia Meng, Yong-Jun Wang
Safety and Efficacy of Reteplase Versus Alteplase for Acute Ischemic Stroke: A Phase 2 Randomized Controlled Trial. Stroke 55 (2) (2023)
Yun-Yun Xiong, Liyuan Wang, Guangshuo Li, Kai-Xuan Yang, Manjun Hao, Shuya Li, Yuesong Pan, Yong-Jun Wang
Tenecteplase versus alteplase for acute ischaemic stroke: a meta-analysis of phase III randomised trials. Stroke and vascular neurology (2023)
Shuya Li, Xuechun Wang, Aoming Jin, Gaifen Liu, Hong-Qiu Gu, Hao Li, Bruce C V Campbell, Marc Fisher, Yi Yang, Yan Wei, Junhai Wang, Yilong Wang, Xing-Quan Zhao, Li-Ping Liu, Zi-Xiao Li, Xia Meng, Yong-Jun Wang
Safety and Efficacy of Reteplase Versus Alteplase for Acute Ischemic Stroke: A Phase 2 Randomized Controlled Trial. Stroke 55 (2) (2023)
Shuya Li, Xuechun Wang, Aoming Jin, Gaifen Liu, Hong-Qiu Gu, Hao Li, Bruce C V Campbell, Marc Fisher, Yi Yang, Yan Wei, Junhai Wang, Yilong Wang, Xing-Quan Zhao, Li-Ping Liu, Zi-Xiao Li, Xia Meng, Yong-Jun Wang
Safety and Efficacy of Reteplase Versus Alteplase for Acute Ischemic Stroke: A Phase 2 Randomized Controlled Trial. Stroke 55 (2) (2023)
Shuya Li, Bruce C V Campbell, Lee H Schwamm, Marc Fisher, Mark Parsons, Hao Li, Yue-Song Pan, Yongjun Wang, null null
Tenecteplase Reperfusion therapy in Acute ischaemic Cerebrovascular Events-II (TRACE II): rationale and design. Stroke and vascular neurology (2021)
Shuya Li, Yue-Song Pan, Ziran Wang, Zhigang Liang, Huisheng Chen, Dong Wang, Yi Sui, Xingquan Zhao, Yilong Wang, Wanliang Du, Huaguang Zheng, Yongjun Wang
Safety and efficacy of tenecteplase versus alteplase in patients with acute ischaemic stroke (TRACE): a multicentre, randomised, open label, blinded-endpoint (PROBE) controlled phase II study. Stroke and vascular neurology (2021)